謝承恩

助理教授級主治醫師

專長頭頸癌/鼻咽癌、肝膽胰及大腸直腸癌等
質子放射治療
影像導航強度調控放射治療
立體定位放射線手術
腫瘤生物學及免疫學
學歷長庚大學醫學系
美國德州大學安德森癌症中心博士 腫瘤生物學及免疫學雙主修
經歷2010~2011 臺北市立聯合醫院仁愛院區內科住院醫師
2011~2015 林口長庚放射腫瘤科住院醫師
2015~2017 林口長庚放射腫瘤科一般級主治醫師
2017~2021 林口長庚放射腫瘤科講師級主治醫師
2017~2018 美國德州大學安德森癌症中心 醫師研究員
2018~2022 美國德州大學安德森癌症中心 博士學位進修
2021~    林口長庚放射腫瘤科助理教授級主治醫師
獲獎經驗

2010 林口長庚紀念醫院最佳實習醫師

2013 第十八屆台灣癌症聯合學術年會論文競賽臨床組優等獎

2014 第十九屆台灣癌症聯合學術年會論文競賽臨床組第一名

2015 第二十屆台灣癌症聯合學術年會論文競賽臨床組優等獎

2018 美國放射腫瘤年會最佳論文獎(Best of ASTRO)

2019 美國德州大學安德森癌症中心Ralph B. Arlinghaus, Ph.D. Scholarship

2021 美國癌症免疫學會(SITC) Young Investigator Award - Presidential Travel Award

2021 美國德州大學安德森癌症中心Andrew Sowell-Wade Huggins Scholarship in Cancer Research 

2021~2022 美國德州大學安德森癌症中心Cancer Prevention and Research Institute of Texas (CPRIT) Graduate Scholar 

參與學會American Society for Radiotherapy and Oncology (ASTRO)
Society for Immunotherapy of Cancer (SITC)
European Society for Radiotherapy and Oncology (ESTRO)
台灣放射腫瘤學會
發表論文Publications
(近5年代表作)
  • Hsieh RCE, Krishnan S, Wu RC et al. ATR-mediated CD47 and PD-L1 up-regulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer Science Immunology 2022 Jun 10;7(72):eabl9330. PMID: 30797890 (SCI, IF = 30.63) 
  • Abousaida B, Hsieh CE (co-first), Venkatesulu BP, Krishnan S. Technological Advances in Radiotherapy. Radiotherapy of Liver Cancer. 2021, pp 73-91 (Textbook chapter; Print ISBN: 978-981-16-1814-7)
  • Hsieh CE, Cheng NM, Chou WC et al. Pretreatment primary tumor and nodal SUVmax values on 18F-FDG PET/CT images predict prognosis in patients with salivary gland carcinoma. Clin Nucl Med. 2018 Dec;43(12):869-879. PMID: 30273205 (SCI, IF = 10.782)
  • Hsieh CE, Ho KC, Hsieh CH et al. Pretreatment primary tumor SUVmax on 18F-FDG PET/CT images predicts outcomes in patients with salivary gland carcinoma treated with definitive intensity-modulated radiation therapy. Clin Nucl Med. 2017 Sep;42(9):655-662 (SCI, IF = 10.782)
  • Hsieh CE, Venkatesulu BP, Lee CH et al. Predictors of radiation-induced liver disease in eastern and western patients with hepatocellular carcinoma undergoing proton beam therapy. Int J Radiat Oncol Biol Phys. 2019 Sep 1;105(1):73-86. PMID: 30797890 (SCI, IF = 8.013)
    This article was selected as the Press Highlight for the September 2019 issue of the Red Journal.
  • Chadha AS, Gunther JR, Hsieh CE (co-first) et al. Proton beam therapy outcomes for localized unresectable hepatocellular carcinoma. Radiother Oncol. 2019, 133, 54-61. PMID: 30935582 (SCI, IF = 6.901)
  • Cheng NM, Hsieh CE, Lao CT et al. Prognostic value of tumor heterogeneity and SUVmax of pretreatment 18F-FDG PET/CT for salivary gland carcinoma with high-risk histology. Clin Nucl Med.2019 May; 44 (5), 351-358. (SCI, IF = 10.782)
  • Hsieh CE, Lee LY, Chou YC et al. Nodal failure patterns and utility of elective nodal irradiation in submandibular gland carcinoma treated with postoperative radiotherapy - a multicenter experience. Radiat Oncol. 2018 Sep 21;13(1):184. PMID: 30241545 (SCI, IF = 4.309)
  • Hsieh CE, Lin CY, Hung CY et al. High metastatic node number, not extranodal extension as a node-related prognosticator in pathologically node-positive salivary gland carcinomas. Head & Neck. 2019 Jun;41(6):1572-1582. PMID: 30652371 (SCI, IF = 3.821)